The concordance between DTI parameters—particularly FA and RD—and MAP2 staining supports their translational value as non-invasive biomarkers of post-stroke structural recovery and suggests that HxEV treatment fosters a microenvironment favorable to dendritic and axonal repair in vulnerable regions. This evidence concerns the gene MAP2 and Stroke.